IDH1 and breast carcinoma: To assess whether the lower IDH1 expression levels contributed to breast cancer progression, we performed IHC analysis of tissue microarrays containing adjacent normal tissues (n = 309), ductal carcinoma in situ (DCIS) tissues (n = 120), and IDC tissues (n = 309) obtained from 309 patients with breast cancer.